Synchronous Surgical Treatment of Morbid Obesity and Complex Ventral Hernia After Progressive Pneumoperitoneum and Botulinum Toxin A Injection

Author(s):  
Camillo Leonardo Bertoglio ◽  
Lorenzo Morini ◽  
Gisella Barone ◽  
Valerio Girardi ◽  
Samantha Bozzo ◽  
...  
Hernia ◽  
2019 ◽  
Vol 24 (2) ◽  
pp. 287-293 ◽  
Author(s):  
K. E. Elstner ◽  
J. W. Read ◽  
J. Saunders ◽  
P. H. Cosman ◽  
O. Rodriguez-Acevedo ◽  
...  

2016 ◽  
Vol 31 (2) ◽  
pp. 761-768 ◽  
Author(s):  
Kristen E. Elstner ◽  
John W. Read ◽  
Omar Rodriguez-Acevedo ◽  
Peter H. Cosman ◽  
Anthony N. Dardano ◽  
...  

2017 ◽  
Vol 32 (2) ◽  
pp. 831-839 ◽  
Author(s):  
Omar Rodriguez-Acevedo ◽  
Kristen E. Elstner ◽  
Anita S. W. Jacombs ◽  
John W. Read ◽  
Rodrigo Tomazini Martins ◽  
...  

2022 ◽  
Vol 8 ◽  
Author(s):  
Fu-Xin Tang ◽  
Ning Ma ◽  
Enmin Huang ◽  
Tao Ma ◽  
Chuang-Xiong Liu ◽  
...  

Background: Complex ventral hernia repair can be challenging despite the recent advances in surgical techniques. Here, we aimed to examine the effectiveness of preoperative combined use of botulinum toxin A (BTA) and preoperative progressive pneumoperitoneum (PPP) for surgical preparation of patients with complex ventral hernia.Methods: In this prospective, observational study, we included 22 patients with complex ventral hernia between January 2018 and May 2021. All patients were treated with BTA injections into the lateral abdominal muscles and PPP before hernia repair. The lengths of abdominal wall muscles, the volumes of the incisional hernia (VIH), the volumes of the abdominal cavity (VAC), and the VIH/VAC ratio were measured before and after BTA and PPP using abdominal CT scan. All Hernias were repaired using laparoscopic intra-peritoneal onlay mesh (IPOM) or laparoscopic-open-laparoscopic (LOL) techniques.Results: Imaging showed a significant increase in the mean lateral abdominal muscle length from 13.1 to 17.2 cm/side (p < 0.01). Before and after BTA and PPP, the mean VIH was 894 cc and 1209 cc (P < 0.01), and the mean VAC was 6,692 cc and 9,183 cc (P < 0.01). The VAC increased by 2,491 cc (P < 0.01) and was greater than the mean VIH before PPP. An average reduction of 0.9% of the VIH/VAC ratio after BTA and PPP was obtained (p > 0.05). All hernias were surgically reduced with mesh, hernia recurrence occurred in only two patients.Conclusions: The preoperative combined use of PPP and BTA increased the abdominal volume, lengthened the laterally retracted abdominal muscles, and facilitated laparoscopic closure of large complex ventral hernia.


Hernia ◽  
2016 ◽  
Vol 20 (2) ◽  
pp. 209-219 ◽  
Author(s):  
K. E. Elstner ◽  
A. S. W. Jacombs ◽  
J. W. Read ◽  
O. Rodriguez ◽  
M. Edye ◽  
...  

2015 ◽  
Vol 86 (1-2) ◽  
pp. 79-83 ◽  
Author(s):  
Faisal Farooque ◽  
Anita S. W. Jacombs ◽  
Emmanouel Roussos ◽  
John W. Read ◽  
Anthony N. Dardano ◽  
...  

2021 ◽  
Vol 108 (Supplement_8) ◽  
Author(s):  
Camillo Leonardo Bertoglio ◽  
Lorenzo Morini ◽  
Gisella Barone ◽  
Marianna Maspero ◽  
Bruno Alampi ◽  
...  

Abstract Aim the worldwide increase in morbidly obese patients with complex hernia raises controversies in the choice of the appropriate treatment timing: synchronous bariatric and abdominal wall surgery versus delayed abdominal wall surgery. We report an innovative tailored surgical treatment carried out at our Institution. Material and Methods the approach provided the injection, six weeks before surgery, of 500 international units of botulinum toxin A on either side of the large abdominal wall muscles. Four weeks before surgery pneumoperitoneum was inducted and out-patient daily sessions of progressive insufflation with ambient air were then carried out. Surgery was scheduled 48 days after botulinum injection. Sleeve gastrectomy and simultaneous posterior component separation with transversus abdominis release were performed. Two prosthetic meshes were placed sublay. Results Postoperative superficial surgical site infection was successfully treated with negative pressure wound therapy. At one year follow up no hernia recurrence was recorded while total body weight loss was 31%. Conclusions a delay in ventral hernia repair could worsen quality of life of morbidly obese patients. In such high risk patients, the choice of the best surgical strategy remains controversial. There is great concern in performing bariatric surgery simultaneously to hernia repair, although there is lack of evidence on which is the ideal treatment modality. Synchronous bariatric surgery and complex ventral hernia repair should be approached in high volume centres where a consolidated experience of multidisciplinary team-work is available. Combined botulinum toxin A and preoperative progressive pneumoperitoneum administration allow for a safe resolution of loss of domain.


Sign in / Sign up

Export Citation Format

Share Document